Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer
Clinical trial NCT01091168 · COMPLETED
Trial details
- NCT number
- NCT01091168
- Sponsor
- Pierre Fabre Medicament
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2012-08-27
- Enrollment
- 594
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.